What's the Cost of Keratoconus Diagnosis and Treatment in Italy?
Keratoconus treatment cost in Italy primarily depends on the disease stage and selected approach, with an ophthalmological investigation running from $150 to $320. Key interventions like corneal cross linking (CCL) cost between $1,100 and $2,200, while a corneal transplant ranges from $4,800 to $7,800. Expenses fluctuate based on clinic tier and specialist expertise, offering 25-45% savings compared to the US. Top destinations include Rome, Milan, and Bari.
Typical Keratoconus Treatment Costs in Italy
- Ophthalmological investigation: $150 – $320
- Corneal cross linking (CCL) (one eye): $1,100 – $2,200
- Corneal transplant: $4,800 – $7,800
- Corneal ring implantation: $2,200 – $3,600
Bookimed Expert Insight: For advanced keratoconus requiring surgery, multi-specialty centers in southern Italy offer high-value care. Ospedale Santa Maria in Bari provides surgical options starting around $12,100 with a staff of 400 doctors. Patients seeking premium amenities and central locations should consider Rome. Ospedale San Carlo di Nancy offers high-capacity hospitalization and proximity to Vatican City for international patients.
| Italy | Turkey | Austria | |
|---|---|---|---|
| Corneal transplant | ≈ $4,800 | from $4,000 | ≈ $5,800 |
| Corneal ring implantation | ≈ $2,200 | from $1,700 | ≈ $2,300 |
| Corneal Cross Linking (CCL) (One eye) | ≈ $1,100 | from $1,200 | ≈ $1,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Keratoconus treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Keratoconus treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Keratoconus treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Keratoconus Treatment Centers in Italy: 3 Verified Options and Prices
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Keratoconus Treatment in Italy
What are the primary treatment options available in Italy for keratoconus?
Italy offers advanced keratoconus treatments ranging from minimally invasive stabilization to surgical reconstruction. Primary options include corneal cross-linking (CXL), intrastromal ring implantation, and specialized lens fittings. Leading centers in Rome, Turin, and Bari employ iontophoresis-assisted protocols and topography-guided techniques to preserve vision and halt disease progression.
- Corneal cross-linking: Standard stabilization using riboflavin and UV light to strengthen corneal fibers.
- Intrastromal rings: Small inserts like Ferrara rings placed to flatten the corneal cone.
- Specialty lenses: Custom-fitted scleral and rigid gas permeable (RGP) lenses for visual correction.
- Corneal transplant: Deep anterior lamellar keratoplasty (DALK) replaces damaged layers in advanced cases.
Bookimed Expert Insight: While many search for the lowest price, the real value in Italy lies in multidisciplinary packages. High-capacity centers like Ospedale San Carlo di Nancy in Rome handle 14,000+ patients annually. These facilities often bundle diagnostic topography mapping with procedure fees. This ensures precise tracking of corneal stability without extra out-of-pocket screening costs.
Patient Consensus: Patients emphasize testing scleral lenses before choosing surgery. Many note that specialized fittings in northern cities often provide excellent results without invasive procedures.
Does the Italian National Health Service (SSN) cover keratoconus treatment for international patients?
The Italian National Health Service (SSN) does not cover keratoconus treatment for temporary international visitors. Eligibility requires legal residency or a valid Italian health card. Non-EU visitors typically pay private rates. EU citizens may receive partial coverage only through specific reciprocal agreements or prior home-country authorization.
- Residency requirement: Access requires proving 183+ days of Italian residency.
- Exemption code: Residents use code RF0280 for rare disease treatment exemptions.
- EU status: EHIC cards cover emergencies but not elective keratoconus procedures.
- Private options: Facilities like Ospedale San Carlo di Nancy accept private patients.
Bookimed Expert Insight: Italian public hospitals often function as first-aid facilities for the SSN. Ospedale San Carlo di Nancy in Rome manages over 14,000 patients yearly. This high volume across its 50 departments suggests deep clinical infrastructure. Patients without residency should target such large accredited centers for private care. These institutions often provide more streamlined administrative paths for international self-pay patients than smaller facilities.
Patient Consensus: Patients note that enrolling as a resident can take three months of paperwork. Those without residency should budget for private treatment as the SSN is strict about fiscal documentation.
Which hospitals and specialists are most recognized for keratoconus care in Italy?
Italy is a global leader in keratoconus care, featuring specialists like Dr. Marco Abbondanza and Dr. Paolo Vinciguerra. Top facilities include San Raffaele Hospital in Milan and Ospedale San Carlo di Nancy in Rome. These centers provide advanced corneal cross-linking and microsurgical interventions.
- Specialized techniques: Access epi-on corneal cross-linking, the Athens Protocol, and Ferrara intracorneal rings.
- Leading surgeons: Prof. Paolo Rama and Prof. Massimo Busin specialize in complex corneal transplantation.
- Diagnostic precision: Clinics utilize advanced corneal topography mapping to detect early-stage ectasia and progression.
- High volume: Ospedale San Carlo di Nancy manages over 15,000 patients annually with accredited care.
Bookimed Expert Insight: While public hospitals like Sant'Orsola-Malpighi provide affordable high-volume procedures, they often have significant waiting lists. For urgent stabilization, private centers in Milan and Turin offer faster access to topography-guided treatments. Dr. Paolo Vinciguerra at Humanitas is highly requested for his research-backed protocols, so booking several months in advance is essential for international patients.
Patient Consensus: Patients emphasize that consulting recognized specialists like Dr. Abbondanza or Dr. Vinciguerra early prevents vision loss. Many note that high-quality topography mapping at major Rome and Milan clinics offers better stability than generic optometry services.
Will Corneal Cross-Linking (CXL) eliminate the need for glasses or contact lenses?
Corneal cross-linking (CXL) typically does not eliminate the need for glasses or contact lenses. The procedure serves to stabilize the cornea and halt keratoconus progression. While some patients experience refractive improvements, most continue using corrective lenses to achieve functional vision after the surgery.
- Primary goal: CXL acts as a stabilizer to prevent vision from worsening further.
- Vision stabilization: Most patients notice corneal shape changes stabilize within 3 to 6 months.
- Correction requirements: Spectacles or specialized scleral lenses remain necessary for clear, sharp focus.
- Fit improvement: A flatter corneal surface often makes contact lenses more comfortable to wear.
Bookimed Expert Insight: Italian medical centers like Ospedale San Carlo di Nancy manage high patient volumes with over 14,000 yearly admissions. Data shows that clinics integrated into larger networks, such as GVM Care and Research, offer extensive diagnostic infrastructure. This specialized environment is vital because successful CXL requires precise ophthalmological mapping to determine if the cornea is thick enough for the procedure.
Patient Consensus: Patients often describe CXL as the brakes for their condition rather than a cure for blurry vision. They emphasize that while the procedure stops the disease, specialized scleral lenses are still the real key to seeing clearly afterward.








